cell product

Do we need to assess genomic stability on culture expanded cells for therapy?

by Alexey Bersenev on April 27, 2012 · 0 comments

in cell culture,cell product

Evaluation of overnight storage conditions for hematopoietic cell product

by Alexey Bersenev on April 12, 2012 · 0 comments

in cell product,clinical lab

Medical terminations of pregnancy as a valuable source of fetal neural cells

by Alexey Bersenev on April 2, 2012 · 0 comments

in cell product

Potency assays in cell products development

by Alexey Bersenev on March 21, 2012 · 0 comments

in cell product

Cord blood hematopoietic cells expansion in hollow fiber bioreactor

by Alexey Bersenev on March 14, 2012 · 0 comments

in cell culture,cell product,cord blood,hematopoietic

Cryopreservation could affect the function of mesenchymal stromal cells

by Alexey Bersenev on January 20, 2012 · 1 comment

in cell product,mesenchymal

Genomic stability of clinical-grade mesenchymal stromal cells – a proposal for international initiative

by Alexey Bersenev on January 5, 2012 · 1 comment

in cell product,mesenchymal

Alternatives to animal serum in cell therapy manufacturing

by Alexey Bersenev on December 22, 2011 · 5 comments

in cell culture,cell product

Moving forward to GMP-grade manufacturing of iPS cells

by Alexey Bersenev on December 16, 2011 · 0 comments

in cell product,embryonic/iPS

The concept of “peak serum” in cell therapy products manufacturing

by Alexey Bersenev on December 15, 2011 · 0 comments

in cell culture,cell product

← Previous Entries